Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters

  • Alabama reached $276 million in settlements with Johnson & Johnson (NYSE:JNJ), McKesson Corporation (NYSE:MCK), and Endo International Plc (NASDAQ:ENDP), resolving claims on the opioid addiction crisis, the state attorney general said.
  • McKesson will pay $141 million. JNJ and Endo will pay $70.3 million and $25 million, respectively, Alabama Attorney General Steve Marshall said in a statement. 
  • The three companies will also pay $40 million in attorneys' fees.
  • The companies have denied wrongdoing.
  • J&J, which manufactured the pain medications Duragesic and Nucynta, said it no longer sells prescription opioids in the U.S. Its past marketing efforts were "appropriate and responsible."
  • "These three settlement agreements affirm my decision to decline participation in the national opioid settlements, which did not adequately acknowledge the unique harm that Alabamians have endured," Marshall said.
  • West Virginia on Monday announced a $99 million settlement with J&J and is in the middle of a trial against Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and AbbVie Inc's (NYSE:ABBV) Allergan unit.
  • In March, Florida reached more than $878 million in opioid settlements with CVS Health Corp (NYSE: CVS) and three drugmakers.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.